UCB U.S. News | UCB

UCB's Global Corporate Website

Welcome to UCB in the United States

Healthcare Professionals

Categories

Archives

2026
- March
- February
2025
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
2024
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
2023
- December
- November
- October
- September
- August
- July
- June
- April
- March
- February
- January
2022
- December
- November
- September
- August
- June
- May
- March
- February
- January
2021
- December
- November
- October
- September
- August
- May
- April
- February

Nov

14

New BIMZELX® (bimekizumab-bkzx) Data at ACR Convergence 2024 Highlights UCB’s Efforts to Deliver Differentiated Care for Patients with Psoriatic Arthritis and Axial Spondyloarthritis

Read More

Nov

10

UCB Presents New Five-Year Data on BIMZELX® (bimekizumab-bkzx) in Ankylosing Spondylitis at ACR Convergence 2023

Read More

Nov

09

Advancing Rheumatic Disease Treatment

Read More

Choose a Country